JUNGJIN International Intellectual Property Law Firm
JUNGJIN International Intellectual Property Law Firm is a Seoul-based IP law firm specializing in patent/trademark prosecution, IP-R&D consulting, FTO analysis, and technology transfer, serving biotech/pharma companies, universities, and research institutes across Korea.
- Company typePrivate
- Founded2006
- HeadquartersSeoul, South Korea
- Headcount11–50
- GTM typeB2B
- OfferingServices
What JUNGJIN International Intellectual Property Law Firm does
JUNGJIN International Intellectual Property Law Firm (특허법인 정진) is a Seoul-based intellectual property law firm founded in 2006 by Managing Partner Kim Soon-woong, a former Director of Technology Transfer at Seoul National University R&DB Foundation. The firm specializes in patent and trademark prosecution, IP-R&D strategic consulting, Freedom-to-Operate (FTO) analysis, technology valuation, and technology transfer commercialization. Approximately 72% of its practice is concentrated in the biotechnology and pharmaceutical sectors, and roughly 80% of clients are universities, national research institutes, startups, and SMEs. Since inception, the firm has handled more than 12,000 patent and trademark filings and has sustained technology transfer outcomes exceeding KRW 1 billion annually since 2016, with notable transactions including the 2021 KRIBB NK Cell technology transfer valued at KRW 150 billion and the 2026 Ajou University-RESPIRA Singapore licensing deal for AI-based inhalation capsule technology.
The firm's service portfolio is organized around five practice areas: Patent Prosecution, Overseas/PCT Filing, Litigation/Trials, IP-R&D Strategic Consulting, and Technology Licensing/Commercialization Consulting. It is differentiated by patent big-data-driven IP-R&D methodology, a multidisciplinary team of patent attorneys and technical specialists (veterinarians, pharmacists, biologists, chemists, and engineers), and a wholly-owned consulting subsidiary, the Jungjin IP Strategy Institute (정진지식재산전략연구소), established in 2020. The firm maintains anchor relationships with 40+ Korean universities and 10+ national research institutes and counts EuBiologics, CJ, SCD Pharmaceutical, Quratis, Asan Medical Center, Samsung Medical Center, KRIBB, and the National Marine Biodiversity Institute of Korea among its named clients.
Commercial operations are anchored in a single Seoul headquarters in Guro-gu, with revenue generated through engagement-based professional services fees, patent prosecution retainers, and success-based technology transfer and IP financial services. Marketing and lead generation are driven by thought-leadership columns in IP trade publications, a weekly pharma/biotech IP Issue Clip newsletter, and active participation in domestic and international events such as INTA, the INTERBIZ Bio Partnering Forum, and KAIPS bilateral IP forums. In November 2025, the firm was officially designated as a Technology Transfer Institution by the Minister of Trade, Industry and Energy, and it remains a registered consulting organization for the Korea IP Protection Agency's Pharmaceutical Patent Strategy Support Program (since 2022). Headcount has grown from 18 to 40+ professionals between the firmographic snapshot and late 2024/early 2025, with additional senior technical hires planned for 2026.
JUNGJIN International Intellectual Property Law Firm firmographics
Firmographics- Name
- JUNGJIN International Intellectual Property Law Firm
- Legal name
- 특허법인 정진
- Website
- https://jjpat.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- JUNGJIN International Intellectual Property Law Firm is a Seoul-based IP law firm specializing in patent/trademark prosecution, IP-R&D consulting, FTO analysis, and technology transfer, serving biotech/pharma companies, universities, and research institutes across Korea.
- Ownership category
- akta.pro rank
JUNGJIN International Intellectual Property Law Firm industry classification
Industry- Product category
- Intellectual Property Law Services
- NAICS
- Legal Services (5411)
- SIC
- Services-Legal Services (8111)
- akta.pro industry
- Patent Prosecution & Portfolio ManagementBusiness & Public Services/Professional Services (Legal, Accounting, Consulting)/Intellectual Property (IP) & Patent ServicesIP Licensing, Transactions & Technology TransferBusiness & Public Services/Professional Services (Legal, Accounting, Consulting)/Intellectual Property (IP) & Patent ServicesIP Filing, Annuities & Renewals AdministrationBusiness & Public Services/Professional Services (Legal, Accounting, Consulting)/Intellectual Property (IP) & Patent ServicesIP Search, Watch & Competitive IntelligenceBusiness & Public Services/Professional Services (Legal, Accounting, Consulting)/Intellectual Property (IP) & Patent Services
Keywords
Where JUNGJIN International Intellectual Property Law Firm is headquartered
LocationHeadquarters
- HQ city
- Seoul
- HQ country
- South Korea
- HQ region
- Asia
Offices1 record
Markets served
JUNGJIN International Intellectual Property Law Firm business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Patent and Trademark Filing Services: Domestic and international patent, utility model, design, and trademark prosecution and registration services.
- IP-R&D and Technology Commercialization Consulting: Strategic IP consulting, FTO analysis, patent portfolio construction, and technology transfer services. Technology transfer outcomes have exceeded KRW 1 billion annually since 2016.
- IP Financial Services: Technology valuation, IP investment matching, M&A IP due diligence, and unused patent identification and transfer services.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
JUNGJIN International Intellectual Property Law Firm product offering
Product offeringCore offering
JUNGJIN is a Korean IP law firm providing full-cycle intellectual property services including domestic and international patent and trademark prosecution, PCT/overseas filing, IP litigation and trials, IP-R&D strategic consulting using patent big data analytics, and technology licensing and commercialization. The firm specializes in biotech and pharmaceutical sectors (72% of practice) and serves universities, national research institutes, and biotech/pharma companies with deep technical expertise and end-to-end IP support from R&D planning through technology transfer.
Product overview
JUNGJIN IP Law Firm is an IP services firm offering a comprehensive portfolio of intellectual property services organized around five core practice areas: Patent Prosecution, Overseas/PCT Filing, Litigation/Trials, IP-R&D Strategic Consulting, and Technology Licensing Consulting. The firm operates specialized teams across biotechnology, chemistry, mechanical engineering, electronics, trademarks, and design. Its subsidiary, the Jungjin IP Strategy Institute, provides advanced IP strategy consulting and operates alongside the law firm to deliver full-cycle IP solutions. The firm is particularly strong in bio/pharmaceutical IP (approximately 72% of practice) and was officially designated as a Technology Transfer Institution by the Ministry of Trade, Industry and Energy in November 2025, enabling it to lead IP-based technology transfer, commercialization, and activation.
Differentiator
Problem solved
Functional benefit
Products and services
- Patent Prosecution Services Comprehensive patent filing, prosecution, and registration services covering domestic and international patent applications. Provided to universities, research institutes, biotech/pharma companies, and SMEs.
- Overseas/PCT Filing Services International patent applications through PCT (Patent Cooperation Treaty) and direct filings to foreign patent offices. Provided to clients seeking global patent protection.
- IP Litigation and Trial Services Legal representation in patent litigation, trials, and disputes before the Korean Patent Trial and Appeal Board and courts. Provided to corporations and research institutions facing IP disputes.
- IP-R&D Strategic Consulting Strategic consulting services utilizing patent big data analysis to support R&D planning, prevent duplicate research, and maximize R&D efficiency. Includes patent trend analysis, competitive research theme identification, and patent barrier navigation. Provided to corporate R&D teams and research institutions.
- Technology Licensing and Commercialization Consulting Full-cycle technology transfer and commercialization support from invention counseling to patent registration and technology transfer, including IP investment matching and M&A IP due diligence. Provided to universities, research institutes, and companies seeking to monetize IP assets.
- Utility Model, Design, and Trademark Services Filing and registration services for utility models, industrial designs, trademarks, and copyrights. Provided to corporate clients and brand owners.
Quantifiable outcome
- Technology transfer revenue exceeding KRW 1 billion annually since 2016
- +3 more outcomes
Companies that use JUNGJIN International Intellectual Property Law Firm
Customer profileNamed customers11 records
Segments4 records
Ideal customer profiles3 records
JUNGJIN International Intellectual Property Law Firm technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
JUNGJIN International Intellectual Property Law Firm partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- RESPIRA Pte. Ltd. (Singapore)coreAjou University's Industry-Academic Cooperation Foundation and Singapore RESPIRA signed a License and Material Transfer Agreement for AI-based inhalation capsule technology. Jungjin supported the deal by strategically developing Ajou's natural product patent portfolio. The agreement includes royalties, milestone payments, and material supply, with expected returns exceeding KRW 500 million for Ajou.
- Pusan National University IP-Centered University Project GroupcoreJungjin IP Law Firm signed an MOU with Pusan National University's IP-Centered University Project Group to strengthen cooperation in intellectual property. The partnership aims to promote IP education, enhance patent support services, and foster innovation and IP strategy development for students, researchers, and startups affiliated with the university.
- Ajou UniversitycoreManaging Partner Kim Soon-woong was appointed as Technology Commercialization Advisor for Ajou University. Jungjin has a longstanding relationship supporting Ajou's technology commercialization, including the landmark RESPIRA technology transfer. Jungjin also participates as IP strategy expert in Ajou's MSIT SEED Fast Track program for multifunctional composite materials development.
- Research Development Commercialization Policy Research Association (연구개발사업화정책연구회)minorManaging Partner Kim Soon-woong participated in the founding of the Research Development Commercialization Policy Research Association, serving as a presenter on shared patent issues in international joint research. The association aims to improve Korea's technology commercialization ecosystem through policy research and legislative support.
- Korea Intellectual Property Service Association (KAIPS) IP Overseas Cooperation CommitteecoreJungjin's Managing Partner Kim Soon-woong serves as Vice Chair of the IP Overseas Cooperation Committee of KAIPS. In this role, he participated in the China-Korea IP Service Industry Conference in Beijing (2023) and led cooperation efforts with international IP service associations and firms.
- Beijing IP Service AssociationminorMOU signed between KAIPS and Beijing IP Service Association at the Beijing IP Service Industry Development Forum. Aims to strengthen cooperation between Korean and Chinese IP service industries and promote IP protection and service exports.
- Jungjin IP Strategy Institute (정진지식재산전략연구소)coreJungjin IP Strategy Institute is the affiliated consulting arm of Jungjin IP Law Firm, established in 2020 to provide advanced IP strategy and commercialization consulting. It supports the parent firm in delivering full-cycle IP services from technology discovery to commercialization for universities, companies, and research institutions.
- Korea Technology Commercialization Association (한국기술사업화협회)coreJungjin actively participates in the Korea Technology Commercialization Association's events and initiatives. Managing Partner Kim presented on technology transfer strategies at the 1st Technology Commercialization Innovation Forum (May 2024) and 2025 Korea Tech Festival. The firm is also involved in the association's SPC establishment initiative for private-led technology commercialization.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
JUNGJIN International Intellectual Property Law Firm competitors and assessment
Company assessmentBroad incumbents
- Lee & Ko IP Group (LEE & KO): Korean full-service law firm with substantial IP practice covering patent prosecution, FTO analysis, IP litigation, and licensing. Comparable to Jungjin in offering Korean IP services with biotech expertise, but operates at much larger scale with broader international reach.
- Yoon & Yang (formerly Yoon Yang Kim Shin & Yu): Korean full-service law firm with a notable IP practice including patent prosecution, IP litigation, and biotech/life sciences work. Comparable to Jungjin in offering Korean IP services across technical fields including biotech, but at significantly larger firm scale.
- KIM & CHANG: Korea's largest full-service law firm with a leading intellectual property practice covering prosecution, litigation, licensing, and technology transfer across all technical fields including biotech. Comparable to Jungjin as a domestic Korean IP services competitor with significantly broader resources, international network, and headcount.
- Fish & Richardson: Leading global IP law firm widely regarded as the top U.S. firm for biotech and pharmaceutical patent prosecution and litigation. Comparable to Jungjin in deep biotech specialization and serves as a benchmark for international expansion of biotech IP practices.
- Finnegan: Premier global IP boutique law firm with leading biotech and pharmaceutical patent practice plus technology transfer expertise. Comparable to Jungjin in IP-boutique positioning and biotech/life sciences technology transfer focus, though operating globally with substantially larger scale.
Direct peers
- AST IP (formerly ASTORIA): Korean IP boutique firm with strong biotechnology and pharmaceutical patent prosecution capabilities and technology commercialization support. Directly comparable to Jungjin in biotech IP boutique positioning and Korean market focus.
- Y.P. Lee & Partners (YP): Korean IP boutique law firm specializing in patent prosecution, IP litigation, and IP strategy with notable biotech and pharmaceutical expertise. Closest comparable to Jungjin in terms of IP boutique positioning, biotech specialization, and practice focus.
- HMP Law (formerly Y.S. Chang & Associates): Korean IP boutique law firm with strong biotech and pharmaceutical patent prosecution and litigation practice, plus university technology transfer support. Comparable to Jungjin in firm size, biotech specialization, and service mix.
- DAEKYUNG IP (대경특허법률법인): Korean patent law firm with comprehensive patent prosecution and IP strategy services covering chemistry, biotech, and mechanical fields. Comparable to Jungjin as a direct domestic Korean IP boutique with multi-disciplinary technical expertise and prosecution focus.
Emerging players
- Sterne Kessler: U.S. patent prosecution boutique with renowned biotechnology and pharmaceutical patent practice and deep PTAB/UPC litigation capabilities. Comparable to Jungjin in focused biotech patent specialization though differs in its U.S.-centric geographic focus.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
JUNGJIN International Intellectual Property Law Firm social profiles
Digital presenceJUNGJIN International Intellectual Property Law Firm financial estimates
Financial estimateRevenue estimate
Valuation estimate
JUNGJIN International Intellectual Property Law Firm leadership team
Management profileNumber of profiles
Profiles7 records
JUNGJIN International Intellectual Property Law Firm subsidiaries and ownership
Company hierarchySubsidiaries1 record
JUNGJIN International Intellectual Property Law Firm funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
JUNGJIN International Intellectual Property Law Firm M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about JUNGJIN International Intellectual Property Law Firm
What does JUNGJIN International Intellectual Property Law Firm do?
JUNGJIN is a Korean IP law firm providing full-cycle intellectual property services including domestic and international patent and trademark prosecution, PCT/overseas filing, IP litigation and trials, IP-R&D strategic consulting using patent big data analytics, and technology licensing and commercialization. The firm specializes in biotech and pharmaceutical sectors (72% of practice) and serves universities, national research institutes, and biotech/pharma companies with deep technical expertise and end-to-end IP support from R&D planning through technology transfer.
Is JUNGJIN International Intellectual Property Law Firm a public or private company?
JUNGJIN International Intellectual Property Law Firm is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was JUNGJIN International Intellectual Property Law Firm founded?
JUNGJIN International Intellectual Property Law Firm was founded in 2006. It employs 11 to 50 people.
Where is JUNGJIN International Intellectual Property Law Firm based?
JUNGJIN International Intellectual Property Law Firm is headquartered in Seoul, South Korea, in the Asia region.
How does JUNGJIN International Intellectual Property Law Firm make money?
Three revenue lines are on record. Patent and Trademark Filing Services are the primary driver. The others are IP-R&D and Technology Commercialization Consulting and IP Financial Services.
Who are JUNGJIN International Intellectual Property Law Firm's main competitors?
Broad incumbents on record are Lee & Ko IP Group (LEE & KO), Yoon & Yang (formerly Yoon Yang Kim Shin & Yu), KIM & CHANG, Fish & Richardson and Finnegan. Direct peers are AST IP (formerly ASTORIA), Y.P. Lee & Partners (YP), HMP Law (formerly Y.S. Chang & Associates) and DAEKYUNG IP (대경특허법률법인). Sterne Kessler is listed as an emerging player.
Does JUNGJIN International Intellectual Property Law Firm have an API?
No public API is recorded for JUNGJIN International Intellectual Property Law Firm.
What industry is JUNGJIN International Intellectual Property Law Firm in?
JUNGJIN International Intellectual Property Law Firm's product category is Intellectual Property Law Services. Its primary akta.pro industry code is BPAHAMAA, Patent Prosecution & Portfolio Management, with a secondary code of BPAHAMAF, IP Licensing, Transactions & Technology Transfer. Its NAICS code is 5411 and its SIC code is 8111.